Skip to main content

Publication, Part of

Cancer Survival in England, cancers diagnosed 2016 to 2020, followed up to 2021

National statistics

Publication Date:
16 Feb 2023
Geographic Coverage:
England
National Statistics

Current Chapter

Cancer Survival in England, cancers diagnosed 2016 to 2020, followed up to 2021

View all

Next Chapter

Survival by cancer group
Page contents

Summary

This release summarises the survival of adults diagnosed with cancer in England between 2016 and 2020 and followed to 2021, and children diagnosed with cancer in England between 2002 and 2020 and followed to 2021.

Adult cancer survival estimates are presented by age, deprivation, gender, stage at diagnosis, and geography.

Key Facts

Cancer survival is highest for melanoma of the skin and cancer of the testis

1-year survival is highest for melanoma for both males (97.3%) and females (98.6%). 5-year survival is highest for cancer of the testis in males (93.5%) and for melanoma in females (94.6%). 

Cancer survival is lowest for pancreatic cancer

1-year survival is lowest for pancreatic cancer for both males (27.4%) and females (28.1%). 5-year survival is lowest for pancreatic cancers for both males (8.4%) and females (8.2%).  

Cancer survival is lower in areas with higher deprivation

For most cancers, the survival decreases consistently for each deprivation quintile from least deprived to most deprived. 

Cancer survival varies by stage at diagnosis

5-year survival by stage ranges from 3.5% (stage 4 lung cancer for males) to 101.1% (stage 1 melanoma for females). 

Childhood cancer survival continues to improve

With 5-year survival seeing the greatest improvement over time, from 77.8% in 2002 to 86.2% in 2020. 

All rates presented in main points are age-standardised net survival apart from childhood which is age-standardised overall survival. 

Last edited: 19 April 2023 12:39 pm